MoneyWorks4Me

Pursuant to Regulation 34(2)(f) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Piramal Pharma has submitted the Business Responsibility & Sustainability Report (BRSR) which forms part of the Annual Report for the financial year 2023-24.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1846.20
Dr. Reddys Labs. 1220.05
Cipla 1385.85
Lupin 2060.30
Zydus Lifesciences 1211.60
View more..